Login / Signup

Personalized care approaches to hepatitis C therapy: recent advances and future directions.

Schiano Moriello NicolaPinchera BiagioGentile Ivan
Published in: Expert review of anti-infective therapy (2024)
Despite pivotal trials demonstrating efficacy rates exceeding 90% for currently available DAA regimens, there are still opportunities to optimize therapy outcomes and tailor treatment to each patient. This can be achieved through a meticulous evaluation of the patient's specific clinical conditions and comorbidities, a vigilant approach to manage potential drug interactions, and diligent patient follow-up.
Keyphrases
  • case report
  • palliative care
  • type diabetes
  • climate change
  • pain management
  • health insurance